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A possible role for the intracellular Ca2+-homeostasis in the 
development of cisplatin-resistance in squamous lung carcinoma 
cells
Huber, Rudolf M.; Oelmez, Hamza; Bergner, Albrecht 
Pneumology, Medizinische Klinik-Innenstadt, LMU, Munich, Germany
Background: In the treatment of lung cancer, the effectiveness of 
chemotherapy is hampered by the development of therapy-resistance. 
Calcium is a universal second messenger involved in the regulation of 
virtually all cell function including apoptosis and cell death. Aim of 
this study was to investigate if the intracellular Ca2+-homeostasis of 
lung cancer cells may inﬂuence the development of therapy-resistance 
to cisplatin.
Methods: ATP served as an agonist to stimulate squamous lung 
carcinoma cells (EPLC) and the increase in cytoplasmatic calcium 
([Ca2+]c) was quantiﬁed using ﬂuorescence microscopy. The Ca2+-
indicator rhod-2 was used to quantify the mitochondrial Ca2+-con-
tent. EPLC cells were exposed to 0.5, 1 and 2 µg/ml cisplatin for 3h 
simulating the in vivo pharmacokinetics. The Ca2+-chelator BAPTA 
was used to study the effects of a reduced [Ca2+]c on the effectiveness 
of cisplatin.
Results: Using appropriate inhibitors, we could show that the ATP-
induced Ca2+-increase was due to Ca2+-release from the sarcoplasmic 
reticulum involving IP3- and Ryanodine-receptors with Ca2+-inﬂux 
from the extracellular space playing a minor role. Exposure to cisplatin 
led to a time dependent increase in the mitochondrial Ca2+-content. 
After 4 “cycles” of cisplatin the EPLC cells showed an increased 
survival compared to naïve EPLC cells. This therapy-resistance could 
be mimicked buffering [Ca2+]c with BAPTA. In the resistant clone, 
the ATP-induced Ca2+-increase was found to be signiﬁcantly reduced 
compared to naïve cells.
Conclusions: The intracellular Ca2+-homeostasis of lung carcinoma 
cells plays a signiﬁcant role in the development of cisplatin-resistance 
and may therefore constitute a novel approach to overcome therapy-
resistance.
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Expression of vascular endothelial growth factors (VEGFs) A, C, D 
and receptors (VEGFRs) 1, 2 and 3, in both tumor cells and tumor 
stroma of non-small cell lung cancer (NSCLC): correlation with 
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Purpose: Nodal status is an important prognostic factor and a major 
determinant for the staging and clinical management of NSCLC. The 
vascular endothelial growth factors (VEGFs) and the vascular endothe-
lial growth factor receptors (VEGFRs) are important molecular markers 
in angiogenesis and lymphangiogenesis. In this study, we aimed to 
extensively investigate the correlations between lymph node metastasis 
and the VEGFs and VEGFRs in tumor cells as well as in the tumor 
stroma.
Methods: Tumor tissue samples from 335 resected patients with stage 
I to IIIA were obtained and tissue microarrays were constructed from 
duplicate cores of tumor cells and surrounding stromal tissue from each 
resected specimen. Immunohistochemistry was used to evaluate the 
expression of VEGF-A, VEGF-C, VEGF-D, VEGFR-1, VEGFR-2 and 
VEGFR-3.
Results: There were 232 lymph node metastasis negative- and 103 
lymph node metastasis positive patients (76 N1, 27 N2). In univariate 
analyses (Chi-square test), high tumor cell expression of VEGF-A (P = 
.011) and VEGFR-3 (P < .001) correlated with lymph node metastasis. 
In tumor stroma, however, low expression of VEGF-A (P = .037) and 
VEGFR-3 (P = .033), correlated with lymph node metastasis. There 
were no signiﬁcant correlations between tumor cell or stromal expres-
sion of VEGF-C, VEGF-D, VEGFR-1 or VEGFR-2 and lymph node 
metastasis. Though, high tumor cell expression of VEGFR-1 (P = .065) 
and low stromal expression of VEGFR-1 (P = .075) tended towards 
correlation with lymph node metastasis. In multivariate analyses 
(Binary logistic regression), including clinicopathogical variables and 
angiogenic markers, high tumor cell expression of VEGF-A (P = .032, 
HR 1.8, 95% CI 1.1-3.1), low stromal expression of VEGF-A (P = .025, 
HR 3.1, 95% CI 1.2 - 8.3) and poor differentiation (P < .001, HR 3.4, 
95% CI 2.0-5.9) correlated with lymph node positive patients. High tu-
mor cell expression of VEGFR-3 (P < .001, HR 6.1, 95% CI 2.1-17.6) 
and vascular inﬁltration (P = .011, HR 3.9, 95% CI 1.4-11.2) correlated 
with N2 positivity.
Conclusion: In tumor cells, there are strong correlations between high 
VEGFR-3 expression and N2-status and high VEGF-A expression and 
lymph node metastasis. While in stroma, low VEGF-A expression is 
associated with lymph node metastasis.
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Clinicopathologic Implications of minimal genomic alteration 
regions (MAR) identified in non-small cell lung cancer by using 
whole genome array-CGH
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Background: Lung cancer is the most common incident form of malig-
nancy and also the leading cause of cancer death worldwide. Although 
many genomic alterations have been observed in lung cancer, their 
clinicopathological signiﬁcance has not been thoroughly investigated. 
This study screened the genomic aberrations across the whole genome 
of non-small cell lung cancer cells with high-resolution and investi-
gated their clinicopathological implications.
Method: One Mb-resolution array comparative genomic hybridization 
(array-CGH) was applied to 31 squamous cell carcinomas and 24 ad-
enocarcinomas of lung. Copy number alteration was detected by using 
web based array-CGH analysis software named arrayCyGHt (http://ge-
nomics.catholic.ac.kr/arrayCGH/). The recurrent genomic alterations 
were analyzed for the association with the clinicopathological features 
of lung cancer. Signiﬁcance of the association between MAR and 
